Kyle W Becker

8PUBLICATIONS
28CO-AUTHORS
Radiation therapyMolecular targetsInnate immunityBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 23, 2024
Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy.

Lihong Wang-Bishop, Mohamed Wehbe, Lucinda E Pastora

|Feb 22, 2024
A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.

Jessalyn J Baljon, Alexander J Kwiatkowski, Hayden M Pagendarm

|May 05, 2023
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy.

Lihong Wang-Bishop, Blaise R Kimmel, Verra M Ngwa

|Nov 23, 2020
Amphiphilic Polyelectrolyte Graft Copolymers Enhance the Activity of Cyclic Dinucleotide STING Agonists.

Dinh Chuong Nguyen, Daniel Shae, Hayden M Pagendarm

Pageof 2